{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:14:41Z","timestamp":1783379681001,"version":"3.54.6"},"reference-count":101,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.urolonc.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:42:10Z","timestamp":1780101730000},"page":"70-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging role of urinary biomarkers in bladder cancer diagnosis and prognosis"],"prefix":"10.1016","volume":"44","author":[{"given":"Gayatri","family":"Paleru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnana Sree","family":"Singathala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhad","family":"Kural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5117-3522","authenticated-orcid":false,"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.05.001_bib0001","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J Glob Health"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41389-023-00489-9","article-title":"Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions","volume":"12","author":"Doshi","year":"2023","journal-title":"Oncogenesis"},{"issue":"7","key":"10.1016\/j.urolonc.2026.05.001_bib0003","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ijerph21070954","article-title":"Risk factors associated with urothelial bladder cancer","volume":"21","author":"Alouini","year":"2024","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"10.1016\/j.urolonc.2026.05.001_bib0004","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1007\/s11033-023-08689-7","article-title":"Molecular classification of urothelial bladder carcinoma","volume":"50","author":"Schwarzova","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1170124","article-title":"Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs","volume":"13","author":"Grabe-Heyne","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0006","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/OTT.S283891","article-title":"The development of non-invasive diagnostic tools in bladder cancer","volume":"15","author":"Schulz","year":"2022","journal-title":"OncoTargets Ther"},{"issue":"5","key":"10.1016\/j.urolonc.2026.05.001_bib0007","first-page":"384","article-title":"Performance characteristics of urinary cytology in patients presenting with gross and microscopic hematuria","volume":"9","author":"Pan","year":"2021","journal-title":"Am J Clin Exp Urol"},{"issue":"9","key":"10.1016\/j.urolonc.2026.05.001_bib0008","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/diagnostics10090703","article-title":"The role of imaging in bladder cancer diagnosis and staging","volume":"10","author":"Galgano","year":"2020","journal-title":"Diagnostics"},{"issue":"6","key":"10.1016\/j.urolonc.2026.05.001_bib0009","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/cancers12061400","article-title":"Urinary biomarkers in bladder cancer: where do we stand and potential role of extracellular vesicles","volume":"12","author":"Oliveira","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.urolonc.2026.05.001_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/iju.15338","article-title":"Urinary markers for bladder cancer diagnosis: a review of current status and future challenges","volume":"31","author":"Tomiyama","year":"2024","journal-title":"Int J Urol: Off J Jpn Urol Assoc"},{"issue":"21","key":"10.1016\/j.urolonc.2026.05.001_bib0011","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.3390\/cancers17213425","article-title":"Urinary biomarkers in bladder cancer: fDA-approved tests and emerging tools for diagnosis and surveillance","volume":"17","author":"Yang","year":"2025","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.urolonc.2026.05.001_bib0012","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3390\/diagnostics12112696","article-title":"Detection of urinary molecular marker test in urothelial cell carcinoma: a review of methods and accuracy","volume":"12","author":"Bulai","year":"2022","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.urolonc.2026.05.001_bib0013","doi-asserted-by":"crossref","first-page":"872","DOI":"10.21037\/tau-2025-27","article-title":"Current perspectives of urine-based tests for screening and post-treatment monitoring of urothelial carcinoma of the bladder","volume":"14","author":"Miyake","year":"2025","journal-title":"Transl Androl Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2026.05.001_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17081283","article-title":"Novel urinary biomarkers for the detection of bladder cancer","volume":"17","author":"Oyaert","year":"2025","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.urolonc.2026.05.001_bib0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.32604\/or.2024.055155","article-title":"Biomarkers for predicting bladder cancer therapy response","volume":"33","author":"Mihai","year":"2025","journal-title":"Oncol Res"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22577-3","article-title":"Urine stabilization and normalization strategies favor unbiased analysis of urinary EV content","volume":"12","author":"Vago","year":"2022","journal-title":"Sci rep"},{"issue":"11","key":"10.1016\/j.urolonc.2026.05.001_bib0017","article-title":"Detection of urinary molecular marker test in urothelial cell carcinoma: a review of methods and accuracy","volume":"12","author":"Bulai","year":"2022","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0018","first-page":"1","article-title":"Urinary biomarkers in bladder cancer: fDA-approved and emerging tests","volume":"14","author":"Palou","year":"2025","journal-title":"Transl Cancer Res"},{"issue":"50","key":"10.1016\/j.urolonc.2026.05.001_bib0019","first-page":"88213","article-title":"Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.urolonc.2026.05.001_bib0020","first-page":"228","article-title":"A comparative evaluation of urine tumor markers in diagnosis of transitional cell carcinoma of bladder","volume":"53","author":"Irani","year":"1999","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2026.05.001_bib0021","first-page":"190","article-title":"Diagnostic utility of the ImmunoCyt\/uCyt+ test in bladder cancer","volume":"8","author":"Greene","year":"2006","journal-title":"Rev Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.05.001_bib0022","first-page":"2023","article-title":"A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria","volume":"188","author":"O\u2019Sullivan","year":"2012","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.05.001_bib0023","first-page":"97","article-title":"UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing","volume":"26","author":"Hajdinjak","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0024","article-title":"UroVysion FISH test for detecting urothelial carcinoma in urine specimens","volume":"2008","author":"Hajdinjak","year":"2008","journal-title":"Adv Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0090-4295(02)02136-2","article-title":"Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses","volume":"61","author":"Lotan","year":"2003","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2026.05.001_bib0026","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Cornel EB,et al. Performance of the bladder EpiCheck\u2122 methylation test for follow-up of non\u2013muscle-invasive bladder cancer","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur Urol Oncol"},{"issue":"18","key":"10.1016\/j.urolonc.2026.05.001_bib0027","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/diagnostics14182061","article-title":"Analytical validation of the Cxbladder\u00ae detect, triage, and Monitor assays for detection and management of urothelial carcinoma","volume":"14","author":"Harvey","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0028","first-page":"79","article-title":"Potential of an mRNA-based urine assay (Xpert\u00ae Bladder Cancer Detection) in hematuria patients: results from a cohort study","volume":"4","author":"Schmitz-Dr\u00e4ger","year":"2018","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0029","first-page":"6","article-title":"A systematic review of the diagnostic and prognostic value of urinary protein biomarkers in urothelial bladder cancer","volume":"118","author":"D\u2019Costa","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0030","article-title":"Urinary biomarkers in bladder cancer: where do we stand? (Review)","volume":"1","author":"de Oliveira","year":"2020","journal-title":"Urol Open-Access"},{"issue":"2","key":"10.1016\/j.urolonc.2026.05.001_bib0031","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2013.08.052","article-title":"Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and potential clinical implications","volume":"65","author":"Allory","year":"2014","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/BLC-230096","article-title":"Noninvasive tests for bladder cancer detection and surveillance: a systematic review of commercially available assays","volume":"10","author":"Heard","year":"2024","journal-title":"Bladder Can"},{"issue":"6 Suppl 1","key":"10.1016\/j.urolonc.2026.05.001_bib0033","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2005.08.064","article-title":"Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers","volume":"66","author":"Lokeshwar","year":"2005","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0034","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.euo.2019.06.006","article-title":"A novel, non-invasive test enabling bladder cancer detection in urine sediment of patients presenting with haematuria-A prospective multicentre performance evaluation of ADXBLADDER","volume":"3","author":"Dudderidge","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/ijms19010226","article-title":"Evaluation of a new survivin ELISA and UBC\u00ae rapid for the detection of bladder cancer in urine","volume":"19","author":"Gleichenhagen","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.urolonc.2026.05.001_bib0036","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/diagnostics10100745","article-title":"Clinical validation of a urine test (Uromonitor-V2\u00ae) for the surveillance of non-muscle-invasive bladder cancer patients","volume":"10","author":"Sieverink","year":"2020","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.urolonc.2026.05.001_bib0037","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00428-019-02654-1","article-title":"Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology","volume":"476","author":"Rodriguez Pena","year":"2020","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.urolonc.2026.05.001_bib0038","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the bladder EpiCheck\u2122 methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0039","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13148-016-0303-5","article-title":"UroMark-a urinary biomarker assay for the detection of bladder cancer","volume":"9","author":"Feber","year":"2017","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0040","first-page":"52","article-title":"Evaluating diagnostic performance of urinary biomarkers in the surveillance of non\u2011muscle invasive bladder carcinoma: a systematic review","volume":"43","author":"Soorojebally","year":"2025","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.05.001_bib0041","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/cancers15030709","article-title":"Diagnostic performance of biomarkers for bladder cancer detection suitable for community and primary care settings: a systematic review and meta-analysis","volume":"15","author":"Papavasiliou","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.urolonc.2026.05.001_bib0042","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.euf.2024.05.024","article-title":"Diagnostic test accuracy of urinary DNA methylation\u2011based biomarkers for the detection of primary and recurrent bladder cancer: a systematic review and meta-analysis","volume":"10","author":"Silva-Ferreira","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0043","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12916-023-02813-x","article-title":"Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging","volume":"21","author":"Vanarsa","year":"2023","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.urolonc.2026.05.001_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17081283","article-title":"Novel urinary biomarkers for the detection of bladder cancer","volume":"17","author":"Oyaert","year":"2025","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.urolonc.2026.05.001_bib0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/ijo.2025.5724","article-title":"Unleashing the power of urine\u2011based biomarkers in diagnosis, prognosis and monitoring of bladder cancer","volume":"66","author":"Wan","year":"2025","journal-title":"Int J Oncol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0046","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0022-5347(05)67104-2","article-title":"Cytology and fluorescence In situ hybridization for detection of UrHybridization for detection of urothelial carcinoma","volume":"164","author":"Halling","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0047","first-page":"650","article-title":"Urine biomarkers for the diagnosis of bladder cancer: a network meta-analysis","volume":"11","author":"Dong","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0048","article-title":"Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review","volume":"15","author":"Sosorojebally","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0049","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/M15-0997","article-title":"Urinary biomarkers for diagnosis of bladder cancer: a systematic review and meta-analysis","volume":"163","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0050","first-page":"483.e7","article-title":"Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: a meta-analysis","volume":"40","author":"Jie Wang","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0051","first-page":"109","article-title":"The diagnostic accuracy of urine-derived exosomes for bladder cancer: a systematic review and meta-analysis","volume":"22","author":"Zhang","year":"2024","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0052","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12916-023-02813-x","article-title":"Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging","volume":"21","author":"Vanarsa","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0053","first-page":"27","article-title":"Noninvasive tests for bladder cancer detection and surveillance: a systematic review of commercially available assays","volume":"10","author":"Heard","year":"2024","journal-title":"Bladder Can"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0054","first-page":"189","article-title":"Molecular markers in bladder cancer","volume":"36","author":"Soria","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0055","first-page":"109","article-title":"Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma","volume":"102","author":"Lotan","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0056","first-page":"1170","article-title":"The prevalence and impact of urinary marker testing in patients with bladder cancer","volume":"27","author":"Narayan","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369357","article-title":"Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO\/ICUD consensus","volume":"94","author":"Schmitz-Dr\u00e4ger","year":"2015","journal-title":"Urol Int"},{"issue":"4","key":"10.1016\/j.urolonc.2026.05.001_bib0058","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.urolonc.2010.02.011","article-title":"Statistical consideration for clinical biomarker research in bladder cancer","volume":"28","author":"Shariat","year":"2010","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.05.001_bib0059","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.urolonc.2007.06.002","article-title":"UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing","volume":"26","author":"Hajdinjak","year":"2008","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.05.001_bib0060","first-page":"4195","article-title":"Review of non-invasive urinary biomarkers in bladder cancer","volume":"9","author":"Lee","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0061","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00345-018-2503-4","article-title":"Molecular markers in bladder cancer: developments in diagnosis and prognosis","volume":"37","author":"Soria","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0062","unstructured":"European Association of Urology. (2024). EAU guidelines on Non\u2013muscle-invasive bladder cancer. https:\/\/uroweb.org\/guidelines\/non-muscle-invasive-bladder-cancer\u2060"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0063","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/M15-0997","article-title":"Urinary biomarkers for diagnosis of bladder cancer: a systematic review and meta-analysis","volume":"163","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0064","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ctrv.2018.05.012","article-title":"Novel urinary biomarkers for the detection of bladder cancer: a systematic review","volume":"69","author":"Shen Tan","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.urolonc.2026.05.001_bib0065","first-page":"4195","article-title":"Review of non-invasive urinary biomarkers in bladder cancer","volume":"9","author":"Lee","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"11","key":"10.1016\/j.urolonc.2026.05.001_bib0066","first-page":"766","article-title":"Urinary biomarkers in bladder cancer: a review of the current landscape and future directions","volume":"39","author":"Ng","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0067","first-page":"117","article-title":"Recent development of urinary biomarkers for bladder cancer diagnosis and monitoring: technical and biological considerations","volume":"542","author":"Zeng","year":"2023","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.urolonc.2026.05.001_bib0068","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/metabo10060229","article-title":"Standardizing pre-analytical processing of blood and urine samples in metabolomics","volume":"10","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0069","doi-asserted-by":"crossref","unstructured":"Lee, J, Kim, E, Park, J, Choi, S, Lee, M-S, Park, J. Pre-analytical handling conditions and protein marker recovery from urine extracellular vesicles for bladder cancer diagnosis.2023;18:e0291198.","DOI":"10.1371\/journal.pone.0291198"},{"issue":"3","key":"10.1016\/j.urolonc.2026.05.001_bib0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/BLC-160054","article-title":"A systematic review of the diagnostic and prognostic value of urinary protein biomarkers in urothelial bladder cancer","volume":"2","author":"D'Costa","year":"2016","journal-title":"Bladder Can"},{"issue":"6 Suppl 1","key":"10.1016\/j.urolonc.2026.05.001_bib0071","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2005.08.064","article-title":"Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers","volume":"66","author":"Lokeshwar","year":"2005","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.urolonc.2026.05.001_bib0072","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.euf.2024.05.024","article-title":"Diagnostic accuracy of urinary DNA methylation-based biomarkers for detection of primary and recurrent bladder cancer: a systematic review and meta-analysis","volume":"10","author":"Silva-Ferreira","year":"2024","journal-title":"Eur Urol Focus"},{"issue":"11","key":"10.1016\/j.urolonc.2026.05.001_bib0073","first-page":"766","article-title":"Urine biomarkers in bladder cancer: a review of the current landscape and future directions","volume":"39","author":"Ng","year":"2021","journal-title":"Urol Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2026.05.001_bib0074","first-page":"1045","article-title":"The diagnostic accuracy of methylation markers in urine for the detection of bladder cancer: a systematic review","volume":"119","author":"Bosschieter","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12916-023-02813-x","article-title":"Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging","volume":"21","author":"Vanarsa","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0076","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-77781-0","article-title":"Bladder cancer detection in urine by novel methylation markers","volume":"14","author":"Beijert","year":"2024","journal-title":"Sci Rep"},{"issue":"21","key":"10.1016\/j.urolonc.2026.05.001_bib0077","article-title":"Biomarkers of bladder cancer: cell-free DNA, epigenetic modifications and non-coding RNAs","volume":"23","author":"Gu\u017eniar","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0078","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-017-0644-5","article-title":"Liquid biopsy: a step forward towards precision medicine in urologic malignancies","volume":"16","author":"Di Meo","year":"2017","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2026.05.001_bib0079","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/CU9.0000000000000291","article-title":"Unleashing the potential of urine DNA methylation detection: advancements in biomarkers, clinical applications, and emerging technologies","volume":"19","author":"Sun","year":"2025","journal-title":"Curr Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.48083\/KQGP2151","article-title":"Urinary-based markers for bladder cancer detection: technical challenges and future directions","volume":"1","author":"Todenh\u00f6fer","year":"2020","journal-title":"SIUJ"},{"issue":"6","key":"10.1016\/j.urolonc.2026.05.001_bib0081","first-page":"4195","article-title":"Review of non-invasive urinary biomarkers in bladder cancer","volume":"9","author":"Lee","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"4","key":"10.1016\/j.urolonc.2026.05.001_bib0082","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eururo.2017.09.011","article-title":"Monitoring treatment response and metastatic relapse in advanced bladder cancer by liquid biopsy analysis","volume":"73","author":"Birkenkamp-Demtroder","year":"2018","journal-title":"Eur Urol"},{"issue":"18","key":"10.1016\/j.urolonc.2026.05.001_bib0083","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.18.02052","article-title":"Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma","volume":"37","author":"Christensen","year":"2019","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.05.001_bib0084","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.juro.2016.12.096","article-title":"FGFR3, TERT and OTX1 as a urinary biomarker combination for surveillance of patients with bladder cancer in a large prospective multicenter study","volume":"197","author":"Beukers","year":"2017","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.05.001_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149756","article-title":"Multiplex PCR and next generation sequencing for the non-invasive detection of bladder cancer","volume":"11","author":"Ward","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.urolonc.2026.05.001_bib0086","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3390\/cancers17121908","article-title":"Circulating tumor DNA in muscle-invasive bladder cancer: implications for prognosis and treatment personalization","volume":"17","author":"Katsimperis","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.urolonc.2026.05.001_bib0087","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3390\/diagnostics14151643","article-title":"Cognitive targeted prostate biopsy alone for diagnosing clinically significant prostate cancer in selected biopsy-na\u00efve patients: results from a retrospective pilot study","volume":"14","author":"Olivetta","year":"2024","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.urolonc.2026.05.001_bib0088","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1073\/pnas.0611618104","article-title":"CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma","volume":"104","author":"Sharma","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.urolonc.2026.05.001_bib0089","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1817323","article-title":"Erdafitinib in locally advanced or metastatic urothelial carcinoma","volume":"381","author":"Loriot","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.urolonc.2026.05.001_bib0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cac2.12129","article-title":"Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer","volume":"41","author":"Huang","year":"2021","journal-title":"Cancer Commun"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0091","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s11658-023-00442-z","article-title":"Blood-based liquid biopsy:insights into early detection, prediction, and treatment monitoring of bladder cancer","volume":"28","author":"Li","year":"2023","journal-title":"Cell Mol Biol Lett"},{"issue":"5","key":"10.1016\/j.urolonc.2026.05.001_bib0092","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2024.100173","article-title":"Predicting genitourinary cancer tissue-of-origin using urine cell-free DNA fragmentomic features","volume":"5","author":"Chauhan","year":"2024","journal-title":"J Liq Biopsy"},{"issue":"11","key":"10.1016\/j.urolonc.2026.05.001_bib0094","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/cancers13112652","article-title":"Urine as a source of liquid biopsy for cancer","volume":"13","author":"Masanori","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.urolonc.2026.05.001_bib0095","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","article-title":"Photodynamic diagnosis of non-muscleinvasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data","volume":"64","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2026.05.001_bib0096","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/pros.24752","article-title":"Serum (-2)proPSA\/freePSAratio, (-2)proPSA\/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng\/mL","volume":"84","author":"Ferro","year":"2024","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.urolonc.2026.05.001_bib0097","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/ijms22041713","article-title":"Role of exosomal miRNA in bladder cancer: a promising liquid biopsy biomarker","volume":"22","author":"Piao","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urolonc.2026.05.001_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100297","article-title":"Enhancing detection and monitoring of circulating tumor cells: integrative approaches in liquid biopsy advances","volume":"8","author":"Velpula","year":"2025","journal-title":"J Liq Biopsy"},{"issue":"13","key":"10.1016\/j.urolonc.2026.05.001_bib0099","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.3390\/cancers14133272","article-title":"Liquid biopsy in prostate cancer management\u2014current challenges and future perspectives","volume":"14","author":"Crocetto","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2016.01.007","article-title":"Genomic alterations in liquid biopsies from patients with bladder cancer","volume":"70","author":"Birkenkamp-Demtroder","year":"2016","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.05.001_bib0101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/BLC-170140","article-title":"Liquid biopsy-analysis of circulating tumor DNA (ctDNA) in bladder cancer","volume":"4","author":"Todenhofer","year":"2018","journal-title":"Bladder Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:28:01Z","timestamp":1783376881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926005259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":101,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1078143926005259"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.05.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of urinary biomarkers in bladder cancer diagnosis and prognosis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}